[go: up one dir, main page]

NO20013851D0 - Salter med opprettholdt frigivning av farmasoytisk ative peptider samt fremstilling derav - Google Patents

Salter med opprettholdt frigivning av farmasoytisk ative peptider samt fremstilling derav

Info

Publication number
NO20013851D0
NO20013851D0 NO20013851A NO20013851A NO20013851D0 NO 20013851 D0 NO20013851 D0 NO 20013851D0 NO 20013851 A NO20013851 A NO 20013851A NO 20013851 A NO20013851 A NO 20013851A NO 20013851 D0 NO20013851 D0 NO 20013851D0
Authority
NO
Norway
Prior art keywords
ative
peptides
pharmaceutically
salts
preparation
Prior art date
Application number
NO20013851A
Other languages
English (en)
Other versions
NO20013851L (no
Inventor
Horst Bauer
Wolfgang Deger
Werner Sarlikiotis
Michael Damm
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of NO20013851D0 publication Critical patent/NO20013851D0/no
Publication of NO20013851L publication Critical patent/NO20013851L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20013851A 1999-02-08 2001-08-07 Salter med opprettholdt frigivning av farmasoytisk ative peptider samt fremstilling derav NO20013851L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11907699P 1999-02-08 1999-02-08
PCT/EP2000/000697 WO2000047234A1 (en) 1999-02-08 2000-01-29 Sustained release salts of pharmaceutically active peptides and their production

Publications (2)

Publication Number Publication Date
NO20013851D0 true NO20013851D0 (no) 2001-08-07
NO20013851L NO20013851L (no) 2001-09-28

Family

ID=22382454

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013851A NO20013851L (no) 1999-02-08 2001-08-07 Salter med opprettholdt frigivning av farmasoytisk ative peptider samt fremstilling derav

Country Status (31)

Country Link
EP (1) EP1150717B1 (no)
JP (1) JP2002536421A (no)
KR (1) KR100661768B1 (no)
CN (1) CN1203897C (no)
AR (1) AR022537A1 (no)
AT (1) ATE298252T1 (no)
AU (1) AU768882B2 (no)
BG (1) BG65581B1 (no)
BR (1) BR0008786A (no)
CA (1) CA2360110C (no)
CO (1) CO5160256A1 (no)
CZ (1) CZ20012841A3 (no)
DE (1) DE60020939T2 (no)
DK (1) DK1150717T3 (no)
ES (1) ES2242601T3 (no)
HK (1) HK1044719B (no)
HU (1) HUP0200127A3 (no)
IL (2) IL144739A0 (no)
MX (1) MXPA01007983A (no)
NO (1) NO20013851L (no)
NZ (1) NZ513748A (no)
PL (1) PL196094B1 (no)
PT (1) PT1150717E (no)
RU (1) RU2239457C2 (no)
SI (1) SI1150717T1 (no)
SK (1) SK285358B6 (no)
TR (1) TR200102289T2 (no)
TW (1) TWI237568B (no)
UA (1) UA72502C2 (no)
WO (1) WO2000047234A1 (no)
ZA (1) ZA200106467B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100452752B1 (ko) * 2000-04-18 2004-10-12 주식회사 펩트론 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
US6818613B2 (en) 2001-11-07 2004-11-16 Ortho-Mcneil Pharmaceutical, Inc. Aqueous sustained-release formulations of proteins
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
PL208073B1 (pl) * 2002-09-27 2011-03-31 Aeterna Zentaris Gmbh Żelowy preparat farmaceutyczny oraz sposób jego otrzymywania i zestaw do jego wytwarzania
EP1674082A1 (de) 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
CN105878174B (zh) * 2016-04-26 2021-06-29 广州帝奇医药技术有限公司 一种固体分散体及其制备方法与应用
CN113368041B (zh) * 2020-07-17 2023-01-03 丽珠医药集团股份有限公司 药物组合物、缓释制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581169A (en) * 1982-12-21 1986-04-08 Syntex (U.S.A.) Inc. Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
WO1998032423A1 (en) * 1997-01-29 1998-07-30 Takeda Chemical Industries, Ltd. Sustained-release microspheres, their production and use
DE19712718C2 (de) * 1997-03-26 1999-09-23 Asta Medica Ag Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
BG105864A (en) 2002-04-30
DE60020939D1 (de) 2005-07-28
PL350054A1 (en) 2002-11-04
BG65581B1 (bg) 2009-01-30
IL144739A0 (en) 2002-06-30
AU2799700A (en) 2000-08-29
ES2242601T3 (es) 2005-11-16
HUP0200127A3 (en) 2002-08-28
KR20020012158A (ko) 2002-02-15
UA72502C2 (uk) 2005-03-15
HUP0200127A2 (en) 2002-06-29
DE60020939T2 (de) 2006-05-11
TWI237568B (en) 2005-08-11
CA2360110A1 (en) 2000-08-17
BR0008786A (pt) 2001-11-06
CN1203897C (zh) 2005-06-01
NZ513748A (en) 2001-09-28
SI1150717T1 (en) 2005-10-31
ZA200106467B (en) 2001-12-19
DK1150717T3 (da) 2005-09-19
CN1343129A (zh) 2002-04-03
CO5160256A1 (es) 2002-05-30
EP1150717A1 (en) 2001-11-07
IL144739A (en) 2009-09-22
ATE298252T1 (de) 2005-07-15
HK1044719A1 (en) 2002-11-01
JP2002536421A (ja) 2002-10-29
SK11312001A3 (sk) 2002-04-04
AU768882B2 (en) 2004-01-08
SK285358B6 (sk) 2006-11-03
MXPA01007983A (es) 2004-03-26
PT1150717E (pt) 2005-10-31
HK1044719B (zh) 2006-02-10
NO20013851L (no) 2001-09-28
EP1150717B1 (en) 2005-06-22
KR100661768B1 (ko) 2006-12-28
TR200102289T2 (tr) 2001-12-21
RU2239457C2 (ru) 2004-11-10
WO2000047234A1 (en) 2000-08-17
CZ20012841A3 (cs) 2002-03-13
PL196094B1 (pl) 2007-12-31
AR022537A1 (es) 2002-09-04
CA2360110C (en) 2009-10-20

Similar Documents

Publication Publication Date Title
NO2010006I1 (no) Saksagliptin og farmasytisk akseptable salter derav inklusive saksagliptin hydroklorid
NO992097D0 (no) Polymerholdig preparat med kontrollert avgivelse av aktiv forbindelse
NO2010009I1 (no) Dronedaron eller farmasoytisk aksepterbare salter inkludert Dronedaron HCI
HUP0101336A3 (en) Process for the preparation of perindopril and their pharmaceutically acceptable salts
NO2008001I1 (no) Vildagliptin og farmasoytisk akseptable salter derav
SI1435915T1 (sl) Oralne dozirne oblike za propiverin ali njegove farmacevtsko sprejemljive soli s podaljšanim sproščanjem učinkovine
EP1047431A4 (en) PHARMACEUTICAL ACTIVE COMPOUNDS AND METHODS OF USE THEREOF
NO982324L (no) Preparat med regulert avgivelse av biologisk aktiv forbindelse
AU2003235707A8 (en) Immunogenic preparations and vaccines on the basis of mrna
EE04452B1 (et) Farmatseutiliselt aktiivne morfolinool ja selle kasutamine
FI20020892L (fi) Farmaseuttisesti aktiivisia isoindoliinin derivaattoja
DK1148871T3 (da) Gliclazidholdig matrixtablet med forsinket frisætning af aktivt stof efter oral administrering
AU2002346973A1 (en) Oral Dosage Form for Propiverine or its Pharmaceutically Acceptable Salts with an Extended Release of the Active Ingredient
PL354169A1 (en) Pharmaceutically active sulfonamide derivatives
NO2005007I2 (no) Pemetrexed og farmasoytisk akseptable salter derav
HUP0101597A3 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
AU2001292529A1 (en) Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight
NO20001375D0 (no) Legemiddelformulering med kontrollert virkestoffrigivning
NO20013851D0 (no) Salter med opprettholdt frigivning av farmasoytisk ative peptider samt fremstilling derav
HRP20050371A2 (en) Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
EE200100539A (et) Prukalopriidi vesilahus suukaudseks manustamiseksning selle valmistamismeetod
AU2003219574A1 (en) Controlled release formulation comprising benzimidazole derivatives or pharmaceutically acceptable salts thereof with increased stability and method for preparing the same
IL150403A0 (en) NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
DK1206253T3 (da) Faste farmaceutiske præparater med nanosoler af chitosan samt disses fremstilling
NO20020631D0 (no) Formuleringer for parenteral bruk av estramustinfosfat og albumin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application